NAPA Reauthorization Act Public Law 118–92 NAPA Reauthorization Act 92 118–92 Statute Compilation United States House of Representatives Office of the Legislative Counsel text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. GPO Statute Compilations USLM converter, version 20240419 2024-10-25 NAPA Reauthorization Act 17726 118 2024-10-01 NAPA Reauthorization Act [(Public Law 118–92)] [This law has not been amended] [Currency: This publication is a compilation of the text of Public Law 118–92. It was last amended by the public law listed in the As Amended Through note above and below at the bottom of each page of the pdf version and reflects current law through the date of the enactment of the public law listed at https://www.govinfo.gov/app/collection/comps/] [Note: While this publication does not represent an official version of any Federal statute, substantial efforts have been made to ensure the accuracy of its contents. The official version of Federal law is found in the United States Statutes at Large and in the United States Code. The legal effect to be given to the Statutes at Large and the United States Code is established by statute (1 U.S.C. 112, 204).]
AN ACTTo extend the National Alzheimer’s Project.Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. [42 U.S.C. 11201 note] SHORT TITLE. This Act may be cited as the “NAPA Reauthorization Act”.
SEC. 2. EXTENSION OF PROJECT. Section 2 of the National Alzheimer’s Project Act (42 U.S.C. 11225) is amended— (1) in subsection (c)— (A) in paragraph (2), by striking “and coordination of” and inserting “on, and coordination of,”; (B) in paragraph (4)— (i) by redesignating subparagraphs (A) and (B) as subparagraphs (B) and (C), respectively; and (ii) by inserting before subparagraph (B), as so redesignated, the following: “(A) promotion of healthy aging and reduction and mitigation of risk factors for Alzheimer’s;” ; (C) in paragraph (5)— (i) by inserting “and other underserved populations, including individuals with developmental disabilities such as Down syndrome,” after “populations”; and (ii) by striking “; and” and inserting a semicolon; (D) by redesignating paragraph (6) as paragraph (7); and (E) by inserting after paragraph (5) the following: “(6) provide information on, and promote the adoption of, healthy behaviors that may reduce the risk of cognitive decline and promote and protect cognitive health; and” ; (2) in subsection (d)(2)— (A) by inserting “, across public and private sectors,” after “Nation’s progress”; and (B) by inserting “, including consideration of public-private collaborations, as appropriate” before the period; (3) in subsection (e)— (A) in paragraph (2)— (i) in subparagraph (A), by adding at the end the following: “(xi) A designee of the Department of Justice. “(xii) A designee of the Federal Emergency Management Agency. “(xiii) A designee of the Social Security Administration. “(xiv) 2 or more other designees, as determined by the Secretary of Health and Human Services, at least one of whom has expertise in risk factors associated with the development or the progression of Alzheimer’s.” ; and (ii) in subparagraph (B)— (I) in the matter preceding clause (i), by striking “12” and inserting “15”; (II) in clause (v)— (aa) by striking “2 researchers” and inserting “3 researchers”; and (bb) by striking “; and” and inserting “, including at least one researcher with demonstrated experience in recruitment and retention of underrepresented groups into research or clinical trials related to dementia;”; (III) in clause (vi), by striking the period and inserting a semicolon; and (IV) by adding at the end the following: “(vii) 1 individual with a diagnosis of Alzheimer’s disease; and “(viii) 1 representative from a historically underserved population whose lifetime risk for developing Alzheimer’s is markedly higher than that of other populations.” ; (B) in paragraph (5)— (i) in subparagraph (A)— (I) by striking “an initial evaluation” and inserting “annual evaluations”; and (II) by striking “research, clinical” and inserting “research, risk reduction, public health, clinical”; (ii) in subparagraph (B), by striking “initial”; (iii) in subparagraph (C)— (I) in the matter preceding clause (i), by striking “initial”; and (II) in clause (ii), by inserting “and reduce disparities” before the semicolon; and (iv) in subparagraph (D), by striking “annually thereafter, an evaluation” and inserting “annual evaluations”; and (C) in paragraph (6), by striking “2025” and inserting “2035”; (4) in subsection (g)— (A) in paragraph (1)— (i) by adding “and” after the semicolon; (ii) by striking “that includes an evaluation” and inserting“that includes— “(A) an evaluation;” ; and (iii) by adding at the end the following: “(B) a summary of the Secretary’s process for identifying and updating what conditions constitute Alzheimer’s disease;” ; and (B) in paragraph (3)(A)(ii), by inserting “and reduce disparities” before the semicolon; and (5) in subsection (h), by striking “2025” and inserting “2035”.